JPS5136469A - - Google Patents

Info

Publication number
JPS5136469A
JPS5136469A JP50089119A JP8911975A JPS5136469A JP S5136469 A JPS5136469 A JP S5136469A JP 50089119 A JP50089119 A JP 50089119A JP 8911975 A JP8911975 A JP 8911975A JP S5136469 A JPS5136469 A JP S5136469A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50089119A
Other languages
Japanese (ja)
Other versions
JPS5527062B2 (US06331856-20011218-P00035.png
Inventor
Kurisutofuaa Danirubitsuch Jon
Gaasu Ebansu Ansonii
Resurii Hamu Aran
Tomuson Korin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5136469A publication Critical patent/JPS5136469A/ja
Publication of JPS5527062B2 publication Critical patent/JPS5527062B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP8911975A 1974-07-25 1975-07-21 Expired JPS5527062B2 (US06331856-20011218-P00035.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25
GB41675*[A GB1460389A (en) 1974-07-25 1975-01-06 4-substituted quinazoline cardiac stimulants

Publications (2)

Publication Number Publication Date
JPS5136469A true JPS5136469A (US06331856-20011218-P00035.png) 1976-03-27
JPS5527062B2 JPS5527062B2 (US06331856-20011218-P00035.png) 1980-07-17

Family

ID=26235904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8911975A Expired JPS5527062B2 (US06331856-20011218-P00035.png) 1974-07-25 1975-07-21

Country Status (23)

Country Link
US (1) US4001422A (US06331856-20011218-P00035.png)
JP (1) JPS5527062B2 (US06331856-20011218-P00035.png)
AR (7) AR216046A1 (US06331856-20011218-P00035.png)
BG (2) BG27086A3 (US06331856-20011218-P00035.png)
CA (1) CA1060445A (US06331856-20011218-P00035.png)
CH (2) CH611616A5 (US06331856-20011218-P00035.png)
DD (1) DD119046A5 (US06331856-20011218-P00035.png)
DE (1) DE2530894C2 (US06331856-20011218-P00035.png)
DK (1) DK138800B (US06331856-20011218-P00035.png)
FI (1) FI66182C (US06331856-20011218-P00035.png)
FR (1) FR2279406A1 (US06331856-20011218-P00035.png)
GB (1) GB1460389A (US06331856-20011218-P00035.png)
HK (1) HK61879A (US06331856-20011218-P00035.png)
IE (1) IE41838B1 (US06331856-20011218-P00035.png)
IL (1) IL47625A (US06331856-20011218-P00035.png)
KE (1) KE2988A (US06331856-20011218-P00035.png)
LU (1) LU73072A1 (US06331856-20011218-P00035.png)
MY (1) MY8000108A (US06331856-20011218-P00035.png)
NL (1) NL159982C (US06331856-20011218-P00035.png)
PH (1) PH14190A (US06331856-20011218-P00035.png)
RO (3) RO71840A (US06331856-20011218-P00035.png)
SE (1) SE420921B (US06331856-20011218-P00035.png)
YU (3) YU37155B (US06331856-20011218-P00035.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022523105A (ja) * 2019-02-01 2022-04-21 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 免疫応答をモジュレートするenpp1阻害剤および方法

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (US06331856-20011218-P00035.png) 1977-06-03 1981-03-07 Pfizer
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
PE20030417A1 (es) * 2001-09-13 2003-08-06 Smithkline Beecham Plc Derivados de urea como antagonistas del receptor vainilloide
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
AU2003270199A1 (en) * 2002-09-13 2004-04-30 Glaxo Group Limited Urea compounds active as vanilloid receptor antagonists for the treatment of pain
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
EP1758580A4 (en) * 2004-06-24 2008-01-16 Incyte Corp N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT
EP1773773A4 (en) * 2004-06-24 2009-07-29 Incyte Corp AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
NZ551602A (en) * 2004-06-24 2010-11-26 Incyte Corp Amido compounds and their use as pharmaceuticals
US7687665B2 (en) * 2004-06-24 2010-03-30 Incyte Corporation 2-methylprop anamides and their use as pharmaceuticals
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
BRPI0514230A (pt) * 2004-08-10 2008-06-03 Incyte Corp compostos de amido e seu uso como produtos farmacêuticos
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
US20070208001A1 (en) * 2006-03-03 2007-09-06 Jincong Zhuo Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
EP2013163A1 (en) * 2006-05-01 2009-01-14 Incyte Corporation Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
WO2007137066A2 (en) * 2006-05-17 2007-11-29 Incyte Corporation HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
EP1903038A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
EP3941459A4 (en) * 2019-03-19 2022-11-30 Stingray Therapeutics, Inc. QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
DE2121031A1 (en) * 1971-04-29 1972-11-02 Dr. Karl Thomae Gmbh, 7950 Biberach Base-substd quinazolines - thrombocyte aggregation inhibitors
BE793371A (fr) * 1971-12-27 1973-06-27 Sandoz Sa Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
US3838127A (en) * 1972-10-19 1974-09-24 Sandoz Ag 4-(4-(hydroxyalkyl)-1-piperazino)-quinazoline benzoates
GB1417029A (en) * 1973-03-07 1975-12-10 Pfizer Ltd Quinazoline-derived amines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022523105A (ja) * 2019-02-01 2022-04-21 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 免疫応答をモジュレートするenpp1阻害剤および方法

Also Published As

Publication number Publication date
AR214049A1 (es) 1979-04-30
FI752104A (US06331856-20011218-P00035.png) 1976-01-26
RO71841A (ro) 1980-08-15
LU73072A1 (US06331856-20011218-P00035.png) 1977-03-24
FR2279406A1 (fr) 1976-02-20
CH611616A5 (US06331856-20011218-P00035.png) 1979-06-15
CA1060445A (en) 1979-08-14
YU124281A (en) 1983-04-30
AR215882A1 (es) 1979-11-15
BG27744A3 (en) 1979-12-12
IL47625A (en) 1981-01-30
DK337175A (US06331856-20011218-P00035.png) 1976-01-26
DK138800C (US06331856-20011218-P00035.png) 1979-04-09
MY8000108A (en) 1980-12-31
SE420921B (sv) 1981-11-09
KE2988A (en) 1979-09-28
AR214050A1 (es) 1979-04-30
AR216046A1 (es) 1979-11-30
RO71840A (ro) 1982-09-09
IL47625A0 (en) 1975-10-15
YU124181A (en) 1983-04-30
SE7508101L (sv) 1976-01-26
BG27086A3 (bg) 1979-08-15
DE2530894A1 (de) 1976-02-05
IE41838B1 (en) 1980-04-09
FI66182C (fi) 1984-09-10
JPS5527062B2 (US06331856-20011218-P00035.png) 1980-07-17
FI66182B (fi) 1984-05-31
NL7508824A (nl) 1976-01-27
AU8317475A (en) 1977-01-20
DD119046A5 (US06331856-20011218-P00035.png) 1976-04-05
PH14190A (en) 1981-03-26
RO69296A (ro) 1981-08-30
DE2530894C2 (de) 1983-12-22
DK138800B (da) 1978-10-30
AR207895A1 (es) 1976-11-08
FR2279406B1 (US06331856-20011218-P00035.png) 1980-04-30
US4001422A (en) 1977-01-04
NL159982B (nl) 1979-04-17
YU37155B (en) 1984-08-31
IE41838L (en) 1976-01-25
YU184275A (en) 1983-04-27
NL159982C (nl) 1979-09-17
AR212447A1 (es) 1978-07-14
AR213407A1 (es) 1979-01-31
GB1460389A (en) 1977-01-06
HK61879A (en) 1979-09-07
CH608803A5 (US06331856-20011218-P00035.png) 1979-01-31

Similar Documents

Publication Publication Date Title
FR2261781B1 (US06331856-20011218-P00035.png)
FR2279406B1 (US06331856-20011218-P00035.png)
FI750754A (US06331856-20011218-P00035.png)
FR2266507B1 (US06331856-20011218-P00035.png)
FR2293656B3 (US06331856-20011218-P00035.png)
FI751159A (US06331856-20011218-P00035.png)
FR2259313B1 (US06331856-20011218-P00035.png)
FR2269776A1 (US06331856-20011218-P00035.png)
JPS50100329A (US06331856-20011218-P00035.png)
FR2275948B1 (US06331856-20011218-P00035.png)
JPS50100825A (US06331856-20011218-P00035.png)
JPS50102094U (US06331856-20011218-P00035.png)
JPS50102749U (US06331856-20011218-P00035.png)
JPS50102870A (US06331856-20011218-P00035.png)
CH611882A5 (US06331856-20011218-P00035.png)
CH606509A5 (US06331856-20011218-P00035.png)
CH601535A5 (US06331856-20011218-P00035.png)
AU480580A (US06331856-20011218-P00035.png)
AU481044A (US06331856-20011218-P00035.png)
CH1357474A4 (US06331856-20011218-P00035.png)
CH1107074A4 (US06331856-20011218-P00035.png)
BG26152A1 (US06331856-20011218-P00035.png)
BG23188A1 (US06331856-20011218-P00035.png)
BG22732A1 (US06331856-20011218-P00035.png)
DD116357A1 (US06331856-20011218-P00035.png)